Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Orthofix Medical (OFIX) Cost of Revenue (2016 - 2025)

Orthofix Medical's Cost of Revenue history spans 16 years, with the latest figure at $63.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 4.86% year-over-year to $63.6 million, compared with a TTM value of $256.3 million through Dec 2025, up 1.06%, and an annual FY2025 reading of $256.3 million, up 1.06% over the prior year.
  • Cost of Revenue for Q4 2025 was $63.6 million at Orthofix Medical, up from $57.1 million in the prior quarter.
  • The five-year high for Cost of Revenue was $139.7 million in Q4 2021, with the low at -$45.9 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $63.0 million, with a median of $62.6 million recorded in 2024.
  • Year-over-year, Cost of Revenue crashed 132.9% in 2022 and then surged 238.84% in 2023.
  • Tracing OFIX's Cost of Revenue over 5 years: stood at $139.7 million in 2021, then crashed by 132.9% to -$45.9 million in 2022, then surged by 238.84% to $63.8 million in 2023, then grew by 4.75% to $66.8 million in 2024, then decreased by 4.86% to $63.6 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Cost of Revenue are $63.6 million (Q4 2025), $57.1 million (Q3 2025), and $63.6 million (Q2 2025).